Global Implanted Port Market Research Report 2021

The implanted port is a blood vessel or thoracoabdominal access device that is completely implanted in the body, which can reduce the pain and risk of repeated vein, artery, thoracoabdominal puncture.

The global Implanted Port market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Implanted Port volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Implanted Port market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Implanted Port Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Titanium Infusion Port
Plastic Infusion Port

Segment by Application
Intravenous Chemotherapy
Nutritional Support Treatment

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
AngioDynamics
B. Braun Medical
Bard Access Systems
MedComp
Navilyst Medical
Norfolk Medical Products
Smiths Medical
Teleflex
Vygon
PFM Medical
Districlass
Fresenius

Frequently Asked Questions